It will also be important to now test whether AAV9-tMCK-DOK7 administration can have similar beneficial therapeutic effects in DOK7-CMS models22 or other motor neuron disease models such as SMA39 and ALS.29 This evidence concerns the gene DOK7 and amyotrophic lateral sclerosis.